Telecom Healthcare Sector

Milestone Pharmaceuticals

Market Cap: US$80.8m

A biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada.

4DMedical

Market Cap: AU$126.2m

Operates as a medical technology company in the United States and Australia.

Whitehawk Therapeutics

Market Cap: US$80.5m

An oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

Arch Biopartners

Market Cap: US$80.4m

Engages in the development of novel drugs for acute kidney injury and organ damage in Canada.

OncoCyte

Market Cap: US$79.8m

Operates as a precision diagnostics company in the United States and internationally.

Pheton Holdings

Market Cap: US$79.0m

A healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

Medicus Pharma

Market Cap: US$78.9m

A biotech/life sciences company, focused on accelerating the clinical development programs of novel and disruptive therapeutic assets.

Kindly MD

Market Cap: US$78.0m

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

Genenta Science

Market Cap: US$77.7m

A clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy.

Inotiv

Market Cap: US$77.6m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Sutro Biopharma

Market Cap: US$77.0m

Operates as a oncology company.

Syntara

Market Cap: AU$120.2m

Operates as a clinical-stage drug development company that focuses on blood-related cancers in Australia.

CervoMed

Market Cap: US$76.4m

A a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

Veru

Market Cap: US$76.2m

A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).

e-therapeutics

Market Cap: US$76.0m

Engages in drug discovery research activities in the United Kingdom.

ESSA Pharma

Market Cap: US$75.9m

A clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer.

Inovio Pharmaceuticals

Market Cap: US$75.2m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Zynex

Market Cap: US$75.0m

Designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation.

Pyxis Oncology

Market Cap: US$75.0m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Alcidion Group

Market Cap: AU$116.8m

Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.

Satellos Bioscience

Market Cap: CA$104.5m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

SomnoMed

Market Cap: AU$116.7m

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe.

Protect Pharmaceutical

Market Cap: US$74.7m

Primarily focuses on crop farming and agricultural businesses.

Telomir Pharmaceuticals

Market Cap: US$74.4m

A pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mechanism.

Jasper Therapeutics

Market Cap: US$74.1m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.

Sensus Healthcare

Market Cap: US$73.6m

Operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.

I-Mab

Market Cap: US$73.4m

A biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.

Adaptimmune Therapeutics

Market Cap: US$73.3m

A commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom.

Tenaya Therapeutics

Market Cap: US$73.1m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

InspireMD

Market Cap: US$72.3m

A medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific.

Simply Better Brands

Market Cap: CA$100.8m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Unicycive Therapeutics

Market Cap: US$71.3m

A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.

Nuo Therapeutics

Market Cap: US$71.2m

Operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

Vistagen Therapeutics

Market Cap: US$71.0m

A biopharmaceutical company, engages in the development and commercialization of therapies for psychiatric and neurological disorders.

IGM Biosciences

Market Cap: US$70.9m

A biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases.

Cumberland Pharmaceuticals

Market Cap: US$70.5m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally.